Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna litapat
no operation time available
40.26
1 office
active in Legal Services

Giulia Tagliafico has worked on the following 16 EPO patent applications which have been published in the last five years:

EP11726386

ACETYL-CARNITINE FOR USE IN A METHOD FOR INCREASING NEUROGENESIS IN NEURAL TISSUE

IPC classification:
A61K 31/21, A61P 25/16, A61P 25/28
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11788175

COMPOSITION FOR TOPICAL USE FOR TREATING SKIN DISORDERS

IPC classification:
A61K 31/205, A61K 31/355, A61K 31/4188, A61K 31/714, A61P 17/00, A61P 17/02, A61P 17/04, A61P 17/06, A61P 17/08, A61P 17/10
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12716038

COMPOSITION USEFUL FOR THE TREATMENT OF LIPID METABOLISM DISORDERS

IPC classification:
A61K 31/045, A61K 31/05, A61K 31/122, A61K 31/202, A61K 31/205, A61K 31/4415, A61K 31/714, A61K 36/062, A61K 36/899
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11187170

Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine

IPC classification:
A61K 31/205, A61K 31/221, A61K 31/70, A61K 31/7072
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12740137

PHARMACEUTICAL COMPOSITION OF OXIDISED AVIDIN SUITABLE FOR INHALATION

IPC classification:
A61K 9/00, A61K 47/42, A61P 35/00
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12761967

NEW THIO DERIVATIVES BEARING LACTAMS AS POTENT HDAC INHIBITORS AND THEIR USES AS MEDICAMENTS

IPC classification:
A61K 31/397, A61K 31/4015, A61K 31/45, A61K 31/4709, A61P 25/00, A61P 29/00, A61P 33/00, A61P 35/00, C07D 205/08, C07D 207/277, C07D 207/28, C07D 211/78, C07D 401/04
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11790621

COMPOUND HAVING ANTIBACTERIAL ACTIVITY

IPC classification:
A61K 31/573, A61P 31/04
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13161748

Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin

IPC classification:
A61K 9/00, A61K 31/185, A61K 31/205, A61K 31/355, A61K 31/728, A61K 38/04, A61P 27/02
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13182338

Mildronate in ophthalmic disorders

IPC classification:
A61K 31/205, A61P 27/02, A61P 27/06
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11709464

Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency

IPC classification:
A61K 31/205, A61K 31/7048, A61P 9/14
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11776414

DITERPENOID DERIVATIVES ENDOWED OF BIOLOGICAL PROPERTIES

IPC classification:
A61K 31/15, C07C 211/31, C07C 251/34, C07C 251/54, C07D 211/46
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11702470

Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation

IPC classification:
A61K 31/205, A61K 31/7036, A61P 27/02
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11754418

THERAPEUTICAL METHOD FOR THE TREATMENT OF THE LEBER OPTIC NEUROPATHY

IPC classification:
A61K 31/221, A61P 27/02
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10788312

ANTICANCER COMBINATION OF ARTEMISININ-BASED DRUGS AND OTHER CHEMOTHERAPEUTIC AGENTS

IPC classification:
A61K 31/24, A61K 31/335, A61K 31/4745, A61K 31/704, A61P 35/00
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16183471

FOOD AND/OR NUTRACEUTICAL COMPOSITION CONTAINING PEA

IPC classification:
A61K 31/16, A23L 29/00, A23L 5/00
Agent:
Giulia Tagliafico, Litapat
Status:
Request for examination was made
EP15798334

COMPOSITION BASED ON COQ10

IPC classification:
A61K 9/14, A61K 31/122
Agent:
Giulia Tagliafico, Litapat
Status:
Request for examination was made

Please Sign in to use this feature